245 related articles for article (PubMed ID: 27313329)
1. Genetic risk factors for sclerotic graft-versus-host disease.
Inamoto Y; Martin PJ; Flowers ME; Lee SJ; Carpenter PA; Warren EH; Geraghty DE; Lee N; Boeckh MJ; Storer BE; Levine DM; Fan W; Zhao LP; Hansen JA
Blood; 2016 Sep; 128(11):1516-24. PubMed ID: 27313329
[TBL] [Abstract][Full Text] [Related]
2. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
Martin PJ; Levine DM; Storer BE; Warren EH; Zheng X; Nelson SC; Smith AG; Mortensen BK; Hansen JA
Blood; 2017 Feb; 129(6):791-798. PubMed ID: 27872059
[TBL] [Abstract][Full Text] [Related]
4. Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantation.
Petersdorf EW; Malkki M; Horowitz MM; Spellman SR; Haagenson MD; Wang T
Blood; 2013 Mar; 121(10):1896-905. PubMed ID: 23305741
[TBL] [Abstract][Full Text] [Related]
5. High HLA-DP Expression and Graft-versus-Host Disease.
Petersdorf EW; Malkki M; O'hUigin C; Carrington M; Gooley T; Haagenson MD; Horowitz MM; Spellman SR; Wang T; Stevenson P
N Engl J Med; 2015 Aug; 373(7):599-609. PubMed ID: 26267621
[TBL] [Abstract][Full Text] [Related]
6. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
Wetzel L; Wittig S; Gruhn B
J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
[TBL] [Abstract][Full Text] [Related]
7. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.
Robien K; Bigler J; Yasui Y; Potter JD; Martin P; Storb R; Ulrich CM
Biol Blood Marrow Transplant; 2006 Sep; 12(9):973-80. PubMed ID: 16920564
[TBL] [Abstract][Full Text] [Related]
9. HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor.
Nowak J; Nestorowicz K; Graczyk-Pol E; Mika-Witkowska R; Rogatko-Koros M; Jaskula E; Koscinska K; Madej S; Tomaszewska A; Nasilowska-Adamska B; Szczepinski A; Halaburda K; Dybko J; Kuliczkowski K; Czerw T; Giebel S; Holowiecki J; Baranska M; Pieczonka A; Wachowiak J; Czyz A; Gil L; Lojko-Dankowska A; Komarnicki M; Bieniaszewska M; Kucharska A; Hellmann A; Gronkowska A; Jedrzejczak WW; Markiewicz M; Koclega A; Kyrcz-Krzemien S; Mielcarek M; Kalwak K; Styczynski J; Wysocki M; Drabko K; Wojcik B; Kowalczyk J; Gozdzik J; Pawliczak D; Gwozdowicz S; Dziopa J; Szlendak U; Witkowska A; Zubala M; Gawron A; Warzocha K; Lange A
Hum Immunol; 2018 Jun; 79(6):403-412. PubMed ID: 29605688
[TBL] [Abstract][Full Text] [Related]
10. Impact of highly conserved HLA haplotype on acute graft-versus-host disease.
Morishima S; Ogawa S; Matsubara A; Kawase T; Nannya Y; Kashiwase K; Satake M; Saji H; Inoko H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Blood; 2010 Jun; 115(23):4664-70. PubMed ID: 20335219
[TBL] [Abstract][Full Text] [Related]
11. CD31 mismatching affects marrow transplantation outcome.
Grumet FC; Hiraki DD; Brown BWM ; Zehnder JL; Zacks ES; Draksharapu A; Parnes J; Negrin RS
Biol Blood Marrow Transplant; 2001; 7(9):503-12. PubMed ID: 11669217
[TBL] [Abstract][Full Text] [Related]
12. Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
Cardones AR; Sullivan KM; Green C; Chao NJ; Rowe-Nichols K; Bañez LL; Burton CS; Horwitz ME; Long GD; Rao CL; Sarantopoulos S; Sidhu-Malik N; Sung AD; Hall RP
JAMA Dermatol; 2019 Jul; 155(7):833-837. PubMed ID: 30994873
[TBL] [Abstract][Full Text] [Related]
13. Replication of associations between genetic polymorphisms and chronic graft-versus-host disease.
Martin PJ; Fan W; Storer BE; Levine DM; Zhao LP; Warren EH; Flowers ME; Lee SJ; Carpenter PA; Boeckh M; Hingorani S; Yan L; Hu Q; Preus L; Liu S; Spellman S; Zhu X; Pasquini M; McCarthy P; Stram D; Sheng X; Pooler L; Haiman CA; Sucheston-Campbell L; Hahn T; Hansen JA
Blood; 2016 Nov; 128(20):2450-2456. PubMed ID: 27758874
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
[TBL] [Abstract][Full Text] [Related]
15. Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.
Pidala J; Wang T; Haagenson M; Spellman SR; Askar M; Battiwalla M; Baxter-Lowe LA; Bitan M; Fernandez-Viña M; Gandhi M; Jakubowski AA; Maiers M; Marino SR; Marsh SG; Oudshoorn M; Palmer J; Prasad VK; Reddy V; Ringden O; Saber W; Santarone S; Schultz KR; Setterholm M; Trachtenberg E; Turner EV; Woolfrey AE; Lee SJ; Anasetti C
Blood; 2013 Nov; 122(22):3651-8. PubMed ID: 23982174
[TBL] [Abstract][Full Text] [Related]
16. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
[TBL] [Abstract][Full Text] [Related]
17. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
Larsen ME; Kornblit B; Larsen MV; Masmas TN; Nielsen M; Thiim M; Garred P; Stryhn A; Lund O; Buus S; Vindelov L
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1370-81. PubMed ID: 20353833
[TBL] [Abstract][Full Text] [Related]
18. The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease.
Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M
Clin Transplant; 2019 Jun; 33(6):e13537. PubMed ID: 30873642
[TBL] [Abstract][Full Text] [Related]
19. Donor Type and Disease Risk Predict the Success of Allogeneic Hematopoietic Cell Transplantation: A Single-Center Analysis of 613 Adult Hematopoietic Cell Transplantation Recipients Using a Modified Composite Endpoint.
Solh M; Zhang X; Connor K; Brown S; Morris LE; Holland HK; Bashey A; Solomon SR
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2192-2198. PubMed ID: 28864140
[TBL] [Abstract][Full Text] [Related]
20. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms.
Bettens F; Passweg J; Schanz U; Chalandon Y; Heim D; Güngör T; Stussi G; Nicoloso G; Baldomero H; Gratwohl A; Tiercy JM
Biol Blood Marrow Transplant; 2012 Apr; 18(4):608-16. PubMed ID: 21963878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
